2017-2020
Active Years
About NILO-PD
Funded by the Michael J. Fox Foundation, NILO-PD is a Phase II clinical trial to evaluate the safety and tolerability of nilotinib in Parkinson's disease. The CTSDMC is the statistical core for this project.
NILO-PD IS A COMPLETED STUDY
For more information and to view the results of this study, please visit the study website.